| P2093 | author name string | Malek Kamoun | |
| | Kelsey Lloyd | |
| | Deirdre Sawinski | |
| | Jennifer Trofe-Clark | |
| | Meera Gupta | |
| | Paige M Porrett | |
| | Matthew H Levine | |
| | Mary Ann Lim | |
| | Alexander H Morrison | |
| | Christine Limonte | |
| P2860 | cites work | A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 |
| | Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation | Q34124202 |
| | Diagnosis and management of antibody-mediated rejection: current status and novel approaches | Q34841849 |
| | Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure. | Q36509321 |
| | General Right Censoring and Its Impact on the Analysis of Survival Data | Q36538979 |
| | The Other Function: Class II-Restricted Antigen Presentation by B Cells | Q39225428 |
| | "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males | Q39926228 |
| | Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 |
| | Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss | Q40634986 |
| | Predictors and outcomes of delayed graft function after living-donor kidney transplantation | Q41268769 |
| | Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation | Q42635486 |
| | Characterization of N-linked oligosaccharides of an HLA-DR molecule expressed in different cell lines | Q42856119 |
| | Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death | Q43829027 |
| | Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. | Q44092564 |
| | Impact of Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibody C1q-Binding Ability on Kidney Allograft Outcome. | Q47130649 |
| | OPTN/SRTR 2016 Annual Data Report: Kidney | Q47225275 |
| | Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients | Q47313617 |
| | Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. | Q47726666 |
| | Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies | Q49644436 |
| | Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation. | Q50027507 |
| | Changes in successive measures of de novo donor-specific anti-human leukocyte antigen antibodies intensity and the development of allograft dysfunction. | Q50616094 |
| | Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation. | Q50946246 |
| | Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen. | Q51087941 |
| | Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation. | Q51454635 |
| | Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft Survival. | Q51563025 |
| | Pregnancy-induced HLA antibodies respond more vigorously after renal transplantation than antibodies induced by prior transplantation. | Q53451647 |
| | Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. | Q53528863 |
| | Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. | Q53659700 |
| | Impact of persistent and cleared preformed HLA DSA on kidney transplant outcomes. | Q53826509 |
| | "Hyperacute" renal-homograft rejection in man. | Q54626072 |
| | Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report | Q58237352 |
| | Microdroplet Assay of Human Serum Cytotoxins | Q59059757 |
| | Pretransplant Donor-Specific HLA Class-I and -II Antibodies Are Associated With an Increased Risk for Kidney Graft Failure | Q60182181 |
| | Carbohydrate differences in HLA-DR molecules synthesized by alveolar macrophages and blood monocytes | Q69049554 |
| | Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells | Q70067993 |
| | Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation | Q77736829 |
| | Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts | Q85575440 |
| P433 | issue | 8 | |
| P304 | page(s) | e478 | |
| P577 | publication date | 2019-07-25 | |
| P1433 | published in | Transplantation direct | Q27726309 |
| P1476 | title | Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients | |
| P478 | volume | 5 | |